160 related articles for article (PubMed ID: 33691630)
1. miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis of colorectal cancer through targeting S100A4.
Chengling L; Yulin Z; Xiaoyu X; Xingchen L; Sen Z; Ziming W; Xianming C
Mol Med; 2021 Mar; 27(1):23. PubMed ID: 33691630
[TBL] [Abstract][Full Text] [Related]
2. IL4/IL4R signaling promotes the osteolysis in metastatic bone of CRC through regulating the proliferation of osteoclast precursors.
Jin Q; Yang H; Jing Z; Hong-Hua W; Ben-Jing S; Li-Ting W; Li-Juan Y; Wei X; Xia K; Juan W; Wei Z
Mol Med; 2021 Dec; 27(1):152. PubMed ID: 34863091
[TBL] [Abstract][Full Text] [Related]
3. The role of S100A4 for bone metastasis in prostate cancer cells.
Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
[TBL] [Abstract][Full Text] [Related]
4. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.
Mudduluru G; Ilm K; Fuchs S; Stein U
Oncotarget; 2017 Mar; 8(13):21081-21094. PubMed ID: 28423501
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer.
Qian J; Gong ZC; Zhang YN; Wu HH; Zhao J; Wang LT; Ye LJ; Liu D; Wang W; Kang X; Sheng J; Xu W; Liu XL; Wu J; Zheng W
Cell Commun Signal; 2021 Jan; 19(1):9. PubMed ID: 33478523
[TBL] [Abstract][Full Text] [Related]
7. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
[TBL] [Abstract][Full Text] [Related]
8. miR-346-3p promotes osteoclastogenesis via inhibiting TRAF3 gene.
Mao Y; Chen Y; Fu Y; Guan J; Liang M; Zhu Y; Yang F; Li F; Zhang Z; Wan C; Zhou P
In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):533-542. PubMed ID: 32839904
[TBL] [Abstract][Full Text] [Related]
9. CCL7 playing a dominant role in recruiting early OCPs to facilitate osteolysis at metastatic site of colorectal cancer.
Yang H; Jian L; Jin Q; Xia K; Cai-Ru W; Jun S; Chen H; Wei W; Ben-Jing S; Shi-Hong L; Shi-Wei L; Juan W; Wei Z
Cell Commun Signal; 2022 Jun; 20(1):94. PubMed ID: 35715847
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
11. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
12. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
13. GPR84 potently inhibits osteoclastogenesis and alleviates osteolysis in bone metastasis of colorectal cancer.
Jian L; Shi-Wei L; Dan J; Juan W; Wei Z
J Orthop Surg Res; 2023 Jan; 18(1):3. PubMed ID: 36593458
[TBL] [Abstract][Full Text] [Related]
14. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
[TBL] [Abstract][Full Text] [Related]
15. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
Li Z; Yao H; Wang S; Li G; Gu X
J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
[TBL] [Abstract][Full Text] [Related]
16. miRNA-7062-5p Promoting Bone Resorption After Bone Metastasis of Colorectal Cancer Through Inhibiting GPR65.
Chen L; Wang Y; Lu X; Zhang L; Wang Z
Front Cell Dev Biol; 2021; 9():681968. PubMed ID: 34485279
[TBL] [Abstract][Full Text] [Related]
17. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
19. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
